Stay updated on ITI-007 in Schizophrenia: Efficacy Study Clinical Trial

Sign up to get notified when there's something new on the ITI-007 in Schizophrenia: Efficacy Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ITI-007 in Schizophrenia: Efficacy Study Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the treatment plan for patients with schizophrenia who poorly respond or tolerate approved medications, specifically related to the open label ITI-007 treatment protocol.
    Difference
    0.1%
    Check dated 2024-06-06T14:25:19.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' which now includes examples such as a person's general health condition or prior treatments. Additionally, the 'Eligibility Criteria Description' section has been expanded to provide more detailed inclusion and exclusion criteria for study participants.
    Difference
    22%
    Check dated 2024-05-22T21:13:14.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:49:22.000Z thumbnail image

Stay in the know with updates to ITI-007 in Schizophrenia: Efficacy Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ITI-007 in Schizophrenia: Efficacy Study Clinical Trial page.